Cardiff Oncology (CRDF) PT Raised to $10 at Piper Sandler on Initial Trial Data
Tweet Send to a Friend
Piper Sandler analyst Joseph Catanzaro raised the price target on Cardiff Oncology (NASDAQ: CRDF) to $10.00 (from $7.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
